HOW DO PROBIOTICS WORK?
Probiotics maintain the balance in the gut flora and will have a positive effect on the gut flora patterns.4,6
In fact, many gut disorders occur due to an imbalance in the normal gut flora, or a lack of diversity in the gut flora.6,7 Illness or medicines upset the balance ® probiotics restore this balance.4
WHAT ARE THE BENEFITS OF PROBIOTICS?
Health professionals are increasingly recognising the beneficial effects of probiotics on our health, as probiotics play an important role in immunological, digestive and respiratory functions.4
They also have a significant effect in alleviating infectious diseases in children as well as other high-risk groups.4
WHAT CAN PROBIOTICS BE USED FOR?
Probiotics can be used to assist in the treatment and prevention of conditions linked to an imbalance in the gut flora. These conditions include, but are not limited to:1,2,3
- colic in babies
- regurgitation in babies
- childhood constipation
- adult constipation
- functional abdominal pain
- vaginal thrush
- antibiotic associated diarrhoea
- immunity building
Research into the cause of babies’ gut problems has shown gut flora to play a crucial role and many studies focus on probiotic therapy as a treatment for specific conditions affecting the gut, including colic, regurgitation, constipation and abdominal pain.7,8
Reuterina® has demonstrated many benefits in a variety of conditions in babies, as follows:
- Reuterina® Drops Approved Package Insert, August 2009.
- Reuterina Junior® Approved Package Insert, July 2010.
- Reuterina Daily® Approved Package Insert, July 2010.
- Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, 1-4 October 2001.
- Eom T-H, et al. The therapeutic effect of Lactobacillus reuteri in acute diarrhea in infants and toddlers. Korean J Ped 2005;48:986-989.
- Chau K, et al. Probiotics for infantile colic: a randomized double-blind placebo controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 2014;166:74-78.
- Indrio F, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation. A randomised clinical trial. JAMA Pediatr 2014;168:228-233.
- Savino F, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study. Am Acad Pediatrics 2007;119:e124. doi:10.1542/peds.2006-1222.
- Szajewska H, et al. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: A randomized, double-blind, placebo-controlled trial. J Pediatr 2013;162:257-262.
- Coccorullo P, et al. Lactobacillus reuteri (DSM 17938) in infants with Functional Chronic Constipation: A Double-Blind, Randomised, Placebo-controlled study. The Journal of Paediatrics 2010;157(4):598-602.
- Weizman Z, et al. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr 2016;174:160-164.
- Gutierrez-Castrellon P, et al. Diarrhea in Preschool Children and Lactobacillus reuteri: A Randomized Controlled Trial. Pediatrics 2014;133:e904–e909. Data on File.
- Data on File.
065 ZA REUT 11/2020
Related Brochures
childhood-constipation
infant-colic
